PD-L1 expression in liver metastasis: its clinical significance and discordance with primary tumor in colorectal cancer

Xiaoli Wei(Anhui Medical University), Rui‐Hua Xu(Sun Yat-sen University), Jianing Li(Merck & Co., Inc., Rahway, NJ, USA (United States)), Feng‐Hua Wang(Sun Yat-sen University), Xuan Luo(Central South University), Hui Sheng(Sun Yat-sen University), Dongliang Chen(Central South University), Yun Wang(Sun Yat-sen University)

Journal of Translational Medicine

December 1, 2020

10.1186/s12967-020-02636-x

Cited by 42

Related Papers

Circular RNA: metabolism, functions and interactions with proteins

|Molecular Cancer|2020|1.6k

METTL3 facilitates tumor progression via an m6A-IGF2BP2-dependent mechanism in colorectal carcinoma

|Molecular Cancer|2019|868

Erythrocyte–Platelet Hybrid Membrane Coating for Enhanced Nanoparticle Functionalization

|Advanced Materials|2017|756

Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial

|The Lancet|2023|701

The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021

|Cancer Communications|2021|657